461165127	461165127	CD	B-NP	O
|	|	NN	I-NP	O
TCH	TCH	NN	I-NP	O
|	|	NN	I-NP	O
26315455	26315455	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8222493	8222493	CD	B-NP	O
|	|	CC	I-NP	O
4/29/2004	4/29/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
PNEUMONIA	PNEUMONIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/29/2004	4/29/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/7/2005	10/7/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
JARED	JARED	NNP	B-NP	O
PATTER	PATTER	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ATTENDING	ATTENDING	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Roberto	Roberto	NNP	B-NP	O
Holk	Holk	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Cam	Cam	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Syncope	Syncope	NNP	B-NP	O
LIST	LIST	NNP	I-NP	O
OF	OF	IN	B-PP	O
PROBLEMS	PROBLEMS	NNP	B-NP	O
,	,	,	O	O
DIAGNOSES	DIAGNOSES	NNP	B-NP	O
:	:	:	O	O
Pneumonia	Pneumonia	NNP	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
non-ST	non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
prostate	prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
83-year-old	83-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
with	with	IN	B-PP	O
valve	valve	NN	B-NP	O
area	area	NN	I-NP	O
0.9	0.9	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
CABG/PCI	CABG/PCI	NN	I-NP	O
,	,	,	O	O
prostate	prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O
with	with	IN	B-PP	O
question	question	NN	B-NP	O
NSCLC	NSCLC	NN	I-NP	O
vs	vs	IN	B-PP	O
lung	lung	NN	B-NP	O
metastasis	metastasis	NN	I-NP	O
,	,	,	O	O
asbestos	asbestos	NN	B-NP	O
exposure	exposure	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Three	Three	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
admission	admission	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
and	and	CC	O	O
not	not	RB	B-VP	O
admitted	admit	VBN	I-VP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
family	family	NN	B-NP	O
felt	feel	VBD	B-VP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
and	and	CC	O	O
discharged	discharge	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Combivent	Combivent	NNP	I-NP	O
inhaler	inhaler	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
toilet	toilet	NN	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
fell	fall	VBD	B-VP	O
and	and	CC	I-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
.	.	.	O	O

per	per	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
girlfriend	girlfriend	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
remember	remember	VB	I-VP	O
the	the	DT	B-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
his	his	PRP$	B-NP	O
vitals	vital	NNS	I-NP	O
were	be	VBD	B-VP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
99.9	99.9	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
91	91	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
36	36	CD	B-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
132/61	132/61	CD	I-NP	I-DNA
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
89	89	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
which	which	WDT	B-NP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
xray	xray	NN	I-NP	O
showing	show	VBG	B-VP	O
a	a	DT	O	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
opacity	opacity	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
use	use	VB	I-VP	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
can	can	MD	B-VP	O
walk	walk	VB	I-VP	O
approximately	approximately	RB	B-NP	O
50	50	CD	I-NP	O
yards	yard	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
flat	flat	JJ	I-NP	O
surface	surface	NN	I-NP	O
without	without	IN	B-PP	O
being	be	VBG	B-VP	O
limited	limit	VBN	I-VP	O
by	by	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
limited	limit	VBN	I-VP	O
by	by	IN	B-PP	O
some	some	DT	B-NP	O
leg	leg	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
stairs	stair	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
never	never	RB	I-VP	O
had	have	VBD	I-VP	O
syncope	syncope	NN	B-NP	O
before	before	IN	B-PP	O
this	this	DT	B-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
cough	cough	NN	B-NP	O
with	with	IN	B-PP	O
specks	speck	NNS	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
sputum	sputum	NN	I-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
burning	burn	VBG	I-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
or	or	CC	I-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
GI	GI	NN	I-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	O	O
any	any	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
1998	1998	CD	I-NP	O
x4	x4	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
PCI	PCI	NN	I-NP	O
2003	2003	CD	B-NP	O
x	x	CC	I-NP	O
2	2	CD	I-NP	O
stents	stent	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Aortic	Aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
area	area	NN	I-NP	O
0.9	0.9	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
September	September	NNP	B-NP	O
2003	2003	CD	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Lung	Lung	NN	B-NP	O
metastasis	metastasis	NN	I-NP	O
VA	VA	NN	I-NP	O
non-small	non-small	JJ	I-NP	O
cell	cell	NN	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
from	from	IN	B-PP	O
metastatic	metastatic	JJ	B-NP	O
prostate	prostate	NN	I-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	I-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Peptic	Peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Gastric	Gastric	JJ	B-NP	O
AVM	AVM	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Long	Long	JJ	B-NP	O
standing	standing	NN	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Asthma	Asthma	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
diverticulosis	diverticulosis	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81mg	81mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1mg	1mg	NN	B-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
30mg	30mg	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
insulin	insulin	NN	I-NP	O
21	21	CD	B-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	B-NP	O
and	and	CC	O	O
11	11	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
20mg	20mg	NNP	I-NP	O
q.h.s.	q.h.s.	NNP	I-NP	O
,	,	,	O	O
Losartan	Losartan	NNP	B-NP	O
50mg	50mg	CD	I-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	I-NP	O
Norvasc	Norvasc	NNP	I-NP	O
10mg	10mg	CD	I-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	O	O
Pepcid	Pepcid	NNP	B-NP	O
40mg	40mg	NNP	I-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75mg	75mg	NNP	I-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
100mg	100mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Xanax	Xanax	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
prn	prn	NN	I-NP	O
and	and	CC	O	O
Casodex	Casodex	NNP	B-NP	O
50mg	50mg	CD	I-NP	O
po	po	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
wishes	wish	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
DNR/DNI	DNR/DNI	NNP	B-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0.89	0.89	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.3	2.3	CD	B-NP	O
,	,	,	O	O
Hct	Hct	NN	B-NP	B-protein
30.5	30.5	CD	I-NP	I-protein
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
22.15	22.15	CD	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
opacity	opacity	NN	I-NP	O
,	,	,	O	O
question	question	NN	B-NP	O
post	post	NN	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
irregular	irregular	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
lead	lead	NN	I-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
Q	Q	NN	I-NP	O
in	in	IN	B-PP	O
lead	lead	NN	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lateral	lateral	JJ	I-NP	O
leads	lead	NNS	I-NP	O
,	,	,	O	O
lost	lose	VBD	B-VP	O
R	R	NN	B-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
and	and	CC	I-NP	O
V3	V3	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
earlier	earlier	RBR	B-ADVP	O
EKG	EKG	NNP	B-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
2004	2004	CD	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Was	Was	NNP	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
99.9	99.9	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
91	91	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
132/61	132/61	CD	I-NP	I-DNA
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
36	36	CD	B-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
3/6	3/6	CD	I-NP	O
diamond	diamond	NN	I-NP	O
shaped	shape	VBD	B-VP	O
systolic	systolic	JJ	B-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
had	have	VBD	B-VP	O
diminished	diminish	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
and	and	CC	O	O
crackles	crackle	NNS	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
wheezes	wheeze	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
critical	critical	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
with	with	IN	B-PP	O
valve	valve	JJ	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
cm2	cm2	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
present	present	JJ	B-ADJP	O
with	with	IN	B-PP	O
syncope	syncope	NN	B-NP	O
ultimately	ultimately	RB	B-ADVP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
cause	cause	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
possibly	possibly	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
AS	AS	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
presentation	presentation	NN	B-NP	O
he	he	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
with	with	IN	B-PP	O
peak	peak	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0.89	0.89	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
did	do	VBD	B-VP	O
trend	trend	VB	I-VP	O
down	down	RP	B-PRT	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
days	day	NNS	I-NP	O
following	follow	VBG	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Four	Four	CD	B-NP	O
days	day	NNS	I-NP	O
following	follow	VBG	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
ischemic	ischemic	JJ	B-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
did	do	VBD	B-VP	O
resolve	resolve	VB	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Cardiology	Cardiology	NN	B-NP	O
consult	consult	NN	I-NP	O
who	who	WP	B-NP	O
reviewed	review	VBD	B-VP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
and	and	CC	O	O
confirmed	confirm	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
risks	risk	NNS	I-NP	O
of	of	IN	B-PP	O
valvuloplasty	valvuloplasty	NN	B-NP	O
would	would	MD	B-VP	O
outweigh	outweigh	VB	I-VP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
benefits	benefit	NNS	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
percutaneous	percutaneous	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
via	via	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
likewise	likewise	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
indicated	indicate	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
multiple	multiple	JJ	B-NP	O
other	other	JJ	I-NP	O
comorbidities	comorbidity	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Ralph	Ralph	NNP	I-NP	O
Flato	Flato	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
would	would	MD	B-VP	O
like	like	VB	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
him	him	PRP	B-NP	O
one	one	CD	B-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
office	office	NN	I-NP	O
will	will	MD	B-VP	O
contact	contact	VB	I-VP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
family	family	NN	I-NP	O
to	to	TO	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
.	.	.	O	O

Infiltrates	Infiltrate	NNS	B-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
10	10	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
no	no	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
COPD	COPD	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
30mg	30mg	NN	B-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
taper	taper	VB	I-VP	O
10mg	10mg	CD	B-NP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
starting	start	VBG	B-VP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
21	21	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
11	11	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
32	32	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
q.a.m.and	q.a.m.and	NN	I-NP	I-protein
6	6	CD	B-NP	I-protein
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
q.p.m.	q.p.m.	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
likely	likely	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
intravascular	intravascular	JJ	I-NP	O
volume	volume	NN	I-NP	O
depletion	depletion	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
did	do	VBD	B-VP	O
normalize	normalize	RB	B-ADVP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
did	do	VBD	B-VP	O
fall	fall	VB	I-VP	O
gradually	gradually	RB	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
packed	pack	VBD	B-VP	O
red	red	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
his	his	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
30	30	CD	B-NP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
on	on	IN	B-PP	O
10/17/05	10/17/05	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650mg	650mg	NN	I-NP	O
po	po	NN	I-NP	O
q.4.h	q.4.h	NN	I-NP	O
.	.	.	O	O

prn	prn	NN	B-NP	O
,	,	,	I-NP	O
albuterol	albuterol	NN	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulized	nebulize	VBN	B-VP	O
2	2	CD	B-NP	O
q.h.	q.h.	NN	I-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81mg	81mg	NN	I-NP	O
po	po	NN	I-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100mg	100mg	VBD	B-VP	O
po	po	NNP	B-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	O	O
Pepcid	Pepcid	NNP	B-NP	O
40mg	40mg	CD	I-NP	O
po	po	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
ferrous	ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
325mg	325mg	NN	I-NP	O
po	po	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
folate	folate	JJ	B-NP	O
1mg	1mg	NN	I-NP	O
po	po	NN	I-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	O	O
Robitussin	Robitussin	NNP	B-NP	O
10ml	10ml	CD	I-NP	O
po	po	NN	I-NP	O
q.4.h	q.4.h	NN	I-NP	O
.	.	.	O	O

prn	prn	NN	B-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
insulin	insulin	NN	I-NP	O
32	32	CD	B-NP	O
units	unit	NNS	I-NP	O
sub-Q	sub-Q	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
NPH	NPH	NN	B-NP	O
insulin	insulin	NN	I-NP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
sub-Q	sub-Q	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30ml	30ml	CD	I-NP	O
po	po	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
prn	prn	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Reglan	Reglan	NNP	B-NP	O
10mg	10mg	VBD	B-VP	O
po	po	NNP	B-NP	O
q.i.d.	q.i.d.	NNP	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
50mg	50mg	CD	I-NP	O
po	po	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
200mg	200mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
,	,	,	O	O
Oxycodone	Oxycodone	NN	B-NP	O
5-10mg	5-10mg	NN	I-NP	O
po	po	NN	I-NP	O
q.4.h	q.4.h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
30mg	30mg	CD	I-NP	O
po	po	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
taper	taper	VB	I-VP	O
by	by	IN	B-PP	O
10mg	10mg	CD	B-NP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
starting	start	VBG	B-VP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
following	follow	VBG	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
2	2	CD	I-NP	O
tabs	tab	NNS	I-NP	O
po	po	VBP	B-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
30mg	30mg	VBD	B-VP	O
po	po	NNP	B-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	O	O
Casodex	Casodex	NNP	B-NP	O
50mg	50mg	CD	I-NP	O
po	po	NN	I-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	O	O
Losartan	Losartan	NNP	B-NP	O
75mg	75mg	NNP	I-NP	O
po	po	NNP	I-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75mg	75mg	NNP	I-NP	O
po	po	NNP	I-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	O	O
Duo	Duo	NNP	B-NP	O
Nebs	Nebs	NNP	I-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulized	nebulized	JJ	I-NP	O
q.6.h	q.6.h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
darbepoetin	darbepoetin	NN	B-NP	O
alfa	alfa	NN	I-NP	O
40mcg	40mcg	CD	I-NP	O
sub-Q	sub-Q	NN	I-NP	O
q.	q.	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

weeks	week	NNS	B-NP	O
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
tablets	tablet	NNS	I-NP	O
1-2	1-2	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
po	po	NN	I-NP	O
q.6.h	q.6.h	NN	I-NP	O
.	.	.	O	O

prn	prn	JJ	B-NP	O
upset	upset	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
20mg	20mg	CD	I-NP	O
po	po	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-6183726	7-6183726	CD	B-NP	O
RSSten	RSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
SCULL	SCULL	NN	B-NP	O
,	,	,	O	O
JACK	JACK	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LOUTHEN	LOUTHEN	NNP	B-NP	O
,	,	,	O	O
DUSTY	DUSTY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0592271	0592271	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/1/05	3/1/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/1/05	3/1/05	CD	B-NP	O

